Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
As one of the world’s leading experts in the science of estrogen receptor signaling and a pioneer in the development of SERMs and SERDs, Donald McDonnell, PhD, says one of the questions he is asked most frequently is which of these is most suitable and most likely to work best in metastatic breast cancer.